Info

MolecularMD provides the highest quality, most informative molecular diagnostic products and services for the diagnosis and monitoring of personalized medicine. The company is currently focused on oncology and looking for successful candidates with experience in the development of DNA and RNA based diagnostics assays. The company's Management team is lead by SHERIDAN G. SNYDER, LLB (hon), OBE. Mr. Snyder has over 40 years experience in creating successful, sustainable companies. He was an original founder of Genzyme Inc. and, most recently, the CEO of Upstate Inc with former companies having a combined market value of over $18 billion. MolecularMD's Scientific team is lead by BRIAN DRUKER, MD. Dr. Druker is recognized world-wide for his key contributions to the clinical development of Gleevec® for the treatment of CML.